3Helix, Inc.’s Post

New blog from us this week, learn about the advantages CHPs bring to IPF research #IPF #Fibrosis #Research

📢The #Myoglobin Test Cassette is a diagnostic tool designed for the quantitative determination of Myoglobin in whole blood, serum, or plasma. It is used as an aid in the diagnosis of Myocardial Infarction (#MI). The test measures the level of Myoglobin, a protein released into the bloodstream during cardiac muscle damage. By accurately quantifying Myoglobin levels, the test assists healthcare professionals in diagnosing MI and assessing the severity of the condition. The test result is calculated using a Fluorescence Immunoassay Analyzer, which ensures precise and reliable measurements. This enables timely intervention and appropriate treatment strategies for patients suspected of having a #heart attack. The Myoglobin Test Cassette plays a crucial role in early detection and management of MI, contributing to improved patient outcomes.   🔎Learn more: https://lnkd.in/gRSk76t8 #hearthealth #health #MI #Myoglobin #detction #diagnosis #medicaldevices #AllTest #fluorescence

A new preoperative prediction model combining biochemical indicators, conventional #ultrasound, and #CEUS can accurately identify microvascular invasion (MVI) in patients with single HCC ≤ 5cm, showing high accuracy and strong clinical benefit, which can help in decision-making regarding treatment. (Dan Lu et al.) #InsightsIntoImaging 🔗 https://buff.ly/3Z3KnMS

At #ASCO24, Bailey Nelson, MD, and team submit findings on the impact of whole pelvis radiation therapy (WPRT) on gut microbiota and chronic GI toxicity. The study highlights that patients with higher levels of Akkermansia muciniphila, a mucin-degrading bacteria, experience milder GI symptoms post-radiation. This discovery shows the potential for radioprotective gut bacteria therapies to enhance patients' quality of life. Read the full abstract: https://lnkd.in/gikMardV #CancerResearch #GutHealth

In patients with aortic stenosis, higher plasma lipoprotein(a) concentrations were associated with faster rates of hemodynamic progression. https://ja.ma/3BHqcuH

Diagnostic value of combined detection of serum neuron-specific enolase and homocysteine in patients with coronary atherosclerosis, by Liu et al https://lnkd.in/dmxJpm8v #MinervaCardiologyAngiology

This review addresses the complexity of treating pulmonary embolism (PE), highlighting emerging percutaneous interventions like catheter-directed thrombolysis, mechanical thrombectomy, and hybrid approaches. These innovative treatments offer potentially quicker improvements in cardiac and hemodynamic functions and may be suitable for patients at high risk of bleeding, providing an alternative to traditional therapies. However, their comparative safety and efficacy remain to be conclusively determined. This review explores future perspectives, proposing “percutaneous primary pulmonary intervention” as a potential paradigm shift in the field. Simone Finocchiaro https://ow.ly/KyS550R6rSI

https://lnkd.in/e8M_jyg3 Percutaneous treatments for pulmonary embolism (PE) are emerging as alternatives to conventional therapies with recent data, and safety profiles endorsing a shift towards a “primary percutaneous pulmonary intervention” strategy, similar to that for ST-elevation myocardial infarction. In this Eurointervention's state of the art we provide a comprehensive overview of percutaneous management options for PE, with a specific emphasis on catheter-directed treatments and their effect on patient out- comes. 

Regeneron looks to expand label of Eylea HD early next year https://lnkd.in/gFgSQfsZ The high-dose version of Regeneron’s eye treatment Eylea hit its primary endpoint in a late-stage study for macular edema following retinal vein occlusion, a common eye disease where fluids build up in a part of [...]

FiCA hs-cTnI is designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum, plasma or whole blood. The high-sensitivity troponin I plays a critical role in the timely diagnosis of AMI, or heart attacks. Compared to traditional cTnI assays, high-sensitivity troponin I (hs-cTnI) assays can detect lower levels of troponin and smaller changes to a patient's troponin levels, which may be an early indication of AMI. The Medlere FiCA System with streamlined STAT process delivers rapid, precise and actionable high-sensitivity troponin I results in 15 minutes. Explore further details by clicking: Web: www.medlere.com Email: info@medlere.com WhatsApp: +447565748991 #hs-cTnI #high-sensitivitytroponinI #AcuteMyocardialInfarctions #AMI #CardiactroponinI #Heartattacks